SUFU 23 Panel: Beta-3 Agonists in the Treatment of Overactive Bladder

Moderator:  J. Quentin Clemens, MD, FACS
Risk Profile of Anticholinergic Agents vs Beta-3 Agonists
Panelist: Anne M. Suskind, MD, MS, FACS, FPMRS
 Efficacy of Anticholinergic Agents vs Beta-3 Agonists
Panelist: Blayne Welk, MD
 What About Neurogenic Bladder?
Panelist: Christopher S. Elliott, MD, PhD